⌘K
OverviewStock screenerAnalyst actionsTicker roomsCalendar
MarketsInvestorsSign in
StockUnited StatesNasdaqGS

ACAD

Acadia Pharmaceuticals Inc.

Healthcare · Biotechnology

19.73USD

-0.5800 (-2.86%)

Alert
DescriptionHistoricalFinancialsRelative ValueResearchNewsCommunityRoomOptionsPrice Chart ↗Fundamental Chart ↗
ProfileRatiosRevenue & EPS
Reading financial statements from SEC filings…
A first visit to a security takes a few seconds.

Community sentiment

Not enough data yet

A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.

Sign in to share your take on ACAD.

Members' own stated views, weighted by account age and track record on this site (simulated portfolios and calls). Not a forecast or a price signal. How this is worked out
  • Only members whose accounts are at least 14 days old and who have a track record on this site (simulated portfolios and calls) count, and bots never do. A take from anyone else is saved and starts to count the day they qualify.
  • A take fades: it counts half as much after 7 days and drops out after 30.
  • Members with a strong record count more. Everyone else counts together for a capped share, so many accounts cannot outweigh a few strong ones.
  • Nothing is shown until 5 qualifying members have taken part, 2 of them with a strong record. It stays an early read until 3 have one and the sample is large enough.
  • Until 20 members have taken part the marker only says bullish, bearish or mixed, at a fixed spot, and the number of members is given as a band, not a count.
  • The reading is refreshed about every 30 minutes, so a take you have just made will not move it straight away.
  • Your own take is private: only the totals are shown, and never who said what.
Fiscal Year End12/2025
Last Quarter End06/2026 Q2
Current/T12M(USD)
1)

Issue Data

Last PxUSD / 19.73
P/E8.9
Dvd Ind Yld0.0%
P/B2.59
P/S3.0
Curr EV/T12M EBITDA28.8
Mkt Cap (USD)3.4B
Curr EV (USD)2.5B
2)

Per Share Data

EPS T12M2.23
DPS—
Bk Val Per Sh7.59
Rev/Sh6.59
Cash/Sh5.55
Curr Shares Out171.2M
FCF/Sh0.84
3)

Cash Flow Analysis

P/CF21.1
Curr P/FCF23.2
CF/NI0.4
Dvd P/O0.0%
Cash Gen/Cash Reqd—
Csh Dvd Cov—
CFO/Sales14.1%
Eff Interest Rate—
4)

Growth Potential

Dil EPS 1Y Gr69.1%
Cap 1Y Gr67.5%
BPS 1Y Gr64.0%
R&D To Sales29.1%
Retention Rate100.0%
Rev 1Y Gr11.9%
FCF 1Y Gr-33.1%
Assets 1Y Gr31.7%
5)

Profitability

EBITDA0.1B
EBIT0.1B
Operating Margin7.6%
Pretax Margin10.7%
Net Margin33.4%
ROA25.6%
ROE35.7%
ROC—
Asset Turnover0.77
6)

Structure

Current Ratio3.39
Quick Ratio3.11
Debt/Assets4.2%
Debt/Com Eq5.7%
Net Debt/EBITDA-3.56
Tot Debt/Capital5.3%
Gross Margin91.1%
EBIT/Int Exp—

Returns and turnover use the AVERAGE balance over the year, not the closing snapshot. Growth rates compare the two most recent fiscal years.